Clinical trial
Anthrax Vaccine Clinical Trial to Assess Dose Reduction and Route Change
NCT00119067 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00119067 |
|---|---|
| Title | Anthrax Vaccine Clinical Trial to Assess Dose Reduction and Route Change |
| Official title | Anthrax Vaccine Adsorbed: Human Reactogenicity and Immunogenicity Trial to Address Change in Route of Administration and Dose Reduction |
| Acronym | AVRP |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Walter Reed Army Institute of Research (WRAIR) U.S. Fed Baylor College of Medicine University of Alabama at Birmingham Emory University Mayo Clinic |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Biological |
| Interventions | Anthrax Vaccine Adsorbed, Saline injection |
| Enrollment | 1,564 |
| Start date | May 1, 2002 |
| Primary completion | Feb 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | Jul 13, 2005 |
| Last update posted | May 29, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: